Events
Koligo Therapeutics a regenerative medicine and 3D bio-printing company to list on the ASX under the stock ticker “KOL”.
MC Services AG, the international public relations and investor relations firm, announced that it will support, as a media partner, BIO-Europe Spring® 2019, Europe’s largest springtime partnering conference for the global life sciences industry.
Insurance Commissioner Ricardo Lara will hold a public hearing on rising prescription drug and health care costs—including the top 25 drugs for which Californians and their health insurers spent the most money.
A recent report by the U.S. Bureau of Labor Statistics and CBRE Research identified Seattle—which happens to be the BioSpace Bio Forest Hotbed—as the fastest-growing life science market in the top 10 from 2014 to 2017, with a greater than 17-percent growth.
In addition to the planned BioNTech IPO, many other pharma and biotech companies in Europe, Asia and elsewhere shared news for the week.
Technology sneak peek from Ascenion: Seven breakthrough life-science inventions
Adrenomed AG, the vascular integrity company, announced its participation in three upcoming conferences in Europe.
BIO-Europe Spring® 2019 comes to Vienna in two weeks for 13th annual springtime biopharma conference
On March 25–27, the thirteenth annual BIO-Europe Spring® international partnering conference will convene in Vienna, Austria, at the Messe Wien Exhibition and Congress Center.
Sterna biologicals GmbH & Co. KG announced that the company held two Scientific Advisory Board (SAB) meetings to evaluate the phase IIb clinical development program for SB010 in asthma.
GeoVax Labs, Inc. announced its selection as a finalist in two award categories at this year’s 12th Vaccine Industry Excellence (ViE) Awards program, held in conjunction with the 19th World Vaccine Congress.
PRESS RELEASES